[Federal Register Volume 73, Number 185 (Tuesday, September 23, 2008)]
[Notices]
[Page 54841]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-22316]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2) notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c) (4) and 552b(c) (6), Title 5 
U.S.C., as amended. The purpose of this meeting is to evaluate requests 
for preclinical development resources for potential new therapeutics 
for the treatment of cancer. The outcome of the evaluation will be a 
decision whether NCI should support request(s) and make available 
contract resources for development of the potential therapeutic to 
improve the treatment of various forms of cancer. The research 
proposals and the discussions could disclose confidential trade secrets 
or commercial property such as patentable material and personal 
information concerning individuals associated with the proposed 
research projects, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Rapid Access to Intervention Development.
    Date: November 5-6, 2008.
    Time: 1 p.m.-5 p.m.
    Agenda: To evaluate the Rapid Access to Intervention Development 
Portfolio.
    Place: National Institutes of Health, Executive Plaza North, 
Conference Room H, 6130 Executive Boulevard, Rockville, MD 20852.
    Contact Person: Phyllis G. Bryant, Executive Secretary, Program 
Analyst, Developmental Therapeutics Program, National Cancer 
Institute, NIH, 6130 Executive Boulevard, Rm. 8022, Bethesda, MD 
20892, (301) 496-8720, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: September 17, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-22316 Filed 9-22-08; 8:45 am]
BILLING CODE 4140-01-P